Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker

QR Code

Diabetic Nephropathy: Role of Aldosterone and Benefits of Therapy with Aldosterone Receptor Blocker

None

Saved in:

Bibliographic Details
Main Authors:	Yap, Jayson, Saklayen, Mohammad G.
Format:	Electronic Book Chapter
Language:	English
Published:	IntechOpen 2012
Subjects:	Health Sciences
Online Access:	https://www.intechopen.com/chapters/35636
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Diagnosis and Treatment of Primary Aldosteronism
by: Tiryaki, Ozlem, et al.
Published: (2012)

SERUM ALDOSTERONE LEVEL DYNAMICS AND CARDIAC REMODELING IN MYOCARDIAL INFARCTION PATIENTS WITH UNDIFFERENTIATED CONNECTIVE TISSUE DYSPLASIA TREATED WITH SELECTIVE ALDOSTERONE RECEPTOR BLOCKER
by: E. P. Miroshnichenko, et al.
Published: (2018-09-01)

The Renin-Angiotensin-Aldosterone System in Dialysis Patients
by: Morishita, Yoshiyuki, et al.
Published: (2012)

Arterial hypertension and aldosterone
by: V. N. Titov
Published: (2007-12-01)

Adipose Composition Before and After Primary Aldosteronism Treatment Depends on Primary Aldosteronism Subtypes and Plasma Aldosterone Concentration Before the Treatment
by: Eriko Nakano, et al.
Published: (2025-07-01)

ALDOSTERONE AND OBESITY: WHERE TO LOOK FOR THE KEY TO THERAPY?
by: N. T. Vatutin, et al.
Published: (2016-08-01)

Effectiveness of an angiotensin II receptor blocker losartan as monoand combined therapy in hypertensive patients with various levels of renin-angiotensin-aldosterone system activity
by: Sh. V. Akhadov, et al.
Published: (2011-02-01)

Baxdrostat and finerenone: new aldosterone synthase-aldosterone-mineralocorticoid receptor hormonal system inhibitors for the drug treatment of resistant arterial hypertension
by: O. B. Kuzmin, et al.
Published: (2024-10-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes: the role of renin-angiotensin-aldosterone system (literature review) (part 2)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

Effect of C-344T polymorphism of aldosterone synthase gene on variability of antihypertensive therapy with angiotensin II receptor blockers: open randomized controlled clinical trial
by: E. V. Rebrova, et al.
Published: (2024-11-01)

View on the problem of diabetic nephropathy in children and adolescents with type 1 diabetes mellitus: the role of renin-angiotensin-aldosterone system (literature review) (part 1)
by: K. V. Skobeleva, et al.
Published: (2021-06-01)

Determinants of serum aldosterone in Kemerovo Region
by: B. A. Tkhorenko, et al.
Published: (2020-09-01)

Diabetic Nephropathy – Using Herbals in Diabetic Nephropathy Prevention and Treatment – The Role of Ginger (Zingiber officinale) and Onion (Allium cepa) in Diabetics’ Nephropathy
by: Khaki, Arash, et al.
Published: (2012)

Intratumoural aldosterone and CYP11B2 expression levels among different genotypes of aldosterone producing tumours
by: Tobias Åkerström, et al.
Published: (2025-06-01)

The role of aldosterone in the development of atrial fibrillation: modern understanding of problem
by: N. T. Vatutin, et al.
Published: (2019-03-01)

The effect of renin-angiotensin system blockers on aldosterone levels in patients with chronic heart failure with preserved ejection fraction
by: A. N. Shevelok
Published: (2020-12-01)

Effects of T-type calcium channel blockers on renal function and aldosterone in patients with hypertension: a systematic review and meta-analysis.
by: Xue Li, et al.
Published: (2014-01-01)

Drug and Diabetic Nephropathy
by: Rani, Rozina
Published: (2012)

Influence of blockers of the renin-angiotensin-aldosterone system on the functional state of the right ventricle myocardial infarction left ventricular anterior wall
by: G. V. Tolparov
Published: (2016-06-01)

Significance of Advanced Glycation End-Products (AGE) and the Receptor for AGE (RAGE) in Diabetic Nephropathy
by: Kamal, Tarek, et al.
Published: (2012)

Blood aldosterone level in various types of atrial fibrillation
by: N. T. Vatutin, et al.
Published: (2016-02-01)

Arterial hypertension in hypothyrosis: severity and state of renin-aldosteron system
by: G. B. Selivanova, et al.
Published: (2004-06-01)

Renin-angiotensin-aldosterone system in climacteric women with arterial hypertension. Antihypertensive therapy features
by: A. E. Bragina, et al.
Published: (2005-12-01)

ALDOSTERONE ANTAGONISTS. MODERN VIEWS ON THE MECHANISM OF ACTION AND EFFECTS OF SPIRONOLACTONE
by: V. I. Podzolkov, et al.
Published: (2017-05-01)

THE GENDER FEATURES OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: V. I. Podzolkov, et al.
Published: (2016-01-01)

THE EFFECT OF ALDOSTERONE ANTAGONISTS ON THE ELECTROPHYSIOLOGICAL PARAMETERS IN RECURRENCE ATRIAL FIBRILLATION
by: N. T. Vatutin, et al.
Published: (2016-09-01)

GALECTIN 3 AND ALDOSTERONE IN PATIENTS WITH ATRIAL FIBRILLATION AND METABOLIC SYNDROME
by: V. A. lonin, et al.
Published: (2015-04-01)

Acute vascular effects of the angiotensin II receptor antagonist olmesartan in normal subjects: relation to the renin-aldosterone system
by: L. M. Resnick, et al.
Published: (2011-12-01)

POLYMORPHISM C(-344)T OF THE ALDOSTERONE SYNTHASE GENE AND ESSENTIAL ARTERIAL HYPERTENSION
by: O. S. Pavlova, et al.
Published: (2016-12-01)

Distribution of genotypes and alleles of the aldosterone-synthase gene in patients with abdominal obesity
by: D. L. Brovin, et al.
Published: (2015-06-01)

Diabetic Nephropathy; Clinical Characteristics and Treatment Approaches
by: Ertugrul, Derun Taner, et al.
Published: (2011)

Renin-angiotensin-aldosterone system in ISIAH rats with stressinduced arterial hypertension
by: A. D. Dubinina, et al.
Published: (2017-02-01)

Arterial hypertension progression and changing activity of reninangiotensin-aldosterone and sympatho-adrenal systems
by: Sh. V. Akhadov, et al.
Published: (2010-04-01)

Arterial hypertension and Type 2 diabetes mellitus: any benefits for angiotensin II receptor blockers?
by: V. V. Fomin, et al.
Published: (2007-06-01)

Preoperative long-term use of renin-angiotensin-aldosterone system blockers increases the risk of acute kidney injury after coronary artery bypass grafting
by: Xiaokang Xu, et al.
Published: (2025-12-01)

Immunoinflammation in Diabetic Nephropathy: Molecular Mechanisms and Therapeutic Options
by: Lopez-Parra, Virginia, et al.
Published: (2012)

Study of Diabetic Hypertensive Nephropathy in the Local Population of Pakistan
by: Riaz, Samreen, et al.
Published: (2012)

Role of renin-angiotensin-aldosterone system gene polymorphisms in the development of diastolic dysfunction in female patients with hypertension
by: Mariya A. Grenaderova, et al.
Published: (2025-01-01)

Clinical value of sublingual microcirculatory dysfunction for screening for primary aldosteronism in hypertensive patients
by: Wuhao Wang, et al.
Published: (2025-07-01)

LONG-TERM EFFECTS OF OLMESARTAN, AN ANG II RECEPTOR ANTAGONIST, ON BLOOD PRESSURE AND THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM IN HYPERTENSIVE PATIENTS
by: Shuichi Ichikawa, et al.
Published: (2011-06-01)